Download PDF
- Fresenius Medical Care
- Overview
- Last Modified:
- March 20, 2025
- Company type:
- Public
- Industry:
- Healthcare
- Verified:
- No
- No of Employees:
- 100 001 +
- Stock Code:
- FME
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Germany
- Public Interest Score:
- 750+
- Fresenius Medical Care
- General Information
Description
Fresenius is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. In fiscal year 2022, Fresenius generated €21.5 billion in annual revenue with around 190,000 employees (excluding Fresenius Medical Care). As a healthcare company focused on therapy, Fresenius offers system-critical products and services for leading therapies for the care of critically and chronically ill patients.
The Fresenius Group comprises the Operating Companies Fresenius Kabi and Fresenius Helios as well as the Investment Companies Fresenius Medical Care and Fresenius Vamed.
- Fresenius Kabi supplies healthcare products for critically and chronically ill patients
- Fresenius Helios is Europe’s leading private hospital operator
- Fresenius Vamed specializes on project business and management of healthcare facilities
Fresenius continuously develops its business areas. With the #FutureFresenius program, the focus will be on three therapy platforms:
- (Bio)Pharma including clinical nutrition
- MedTech
- Care Provision
With these platforms, Fresenius caters to major trends in healthcare and becomes a more therapy-focused company. The health and quality of life of patients who the company serves with high-quality, affordable products and services is at the core.
At Fresenius, the patient always comes first. For more than 100 years now we have been working to save lives and improve the quality of life of our critically and chronically ill patients. A clear focus on innovation and efficiency has helped us to make world-class therapies accessible to a steadily increasing number of people. Yet we never get complacent about our successes, and never stop looking for better solutions. This is how Fresenius is contributing to medical progress and better patient care.
Success in our business is the key for investing in high-quality yet affordable healthcare. In this way we are meeting our social responsibility to help patients, while ensuring that Fresenius remains successful over the long term.
Fresenius leads by recognizing important trends and developments early, then working with our partners to help shape healthcare systems. Aging populations and the expansion of healthcare provision in countries worldwide are driving demand for medical products and services, and Fresenius is excellently positioned for continuous and profitable growth in the future.
“Advancing patient care” – we strive to improve continuously and to shape the future of healthcare as an industry-leading, therapy-focused healthcare company.
Michael Sen:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sara Hennicken:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Shervin Korangy:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Marcus Kuhnert:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Gregory Sorensen:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Pascale Witz:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stefanie Balling:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ralf Erkens:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Beate Haßdenteufel:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Regina Karsch:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frank Prescher:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Manuela Stauss-Grabo:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Sara Hennicken:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Shervin Korangy:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Marcus Kuhnert:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Gregory Sorensen:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Pascale Witz:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Stefanie Balling:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Ralf Erkens:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Beate Haßdenteufel:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Regina Karsch:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Frank Prescher:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Manuela Stauss-Grabo:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3 Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 15130
- Founded Year:
- 1996
- Registration Number:
- DE 93743709
- Country:
- Germany
- Stock Exchanges:
-
- NASDAQ Stock Exchange
- Financial year end:
- December
- No. of Countries operations:
- 24
- Company Status:
- In Business
- Industry Sub Category:
- Date listed on Stock Exchange:
- 01/10/1996
- Contact Information
- Business operation:
- Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.9 million patients worldwide regularly undergo dialysis treatment.
- Primary office:
- Fresenius Medical Care AG Investor Relations Else-Kröner-Straße 1 61346 Bad Homburg Germany
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Cindy Collins Scherlitz
- Reporting currency:
- EUR
- ISIN number (12 digit):
ETR
DE0005785802- Authorised shares:
- 362 370 124
- Issued shares:
- 293 413 449
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 0 shareholders
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Credit Rating
| Name | Logo | Country | Headquarters | Rating |
|---|---|---|---|---|
| Fitch Ratings | United States of America | New York | BBB- |
Countries Operations/ Offices
Company Directors
Name
Nationality
Age
Role
Qualification
Name
Stefanie
Non ExecutiveNationalityGermany
58
RoleNED
QualificationEnglish Foreign Language Clerk
Name
Ralf
Non ExecutiveNationalityGermany
61
RoleNED
QualificationEnergy System Electronics Technician
Name
Beate
Non ExecutiveNationalityGermany
56
RoleNED
QualificationVocational Education
Name
Regina
Non ExecutiveNationalityGermany
43
RoleNED
QualificationM.A. of Political Science and History
Name
Frank Michael
Non ExecutiveNationalityGermany
63
RoleNED
QualificationRegistered Nurse
Name
Manuela
Non ExecutiveNationalityGermany
58
RoleNED
QualificationDiploma in Biology, Ph.D./Dr. rer. nat. in Pharmacy
Directors Tenure
Name
Duration
Director Experience
Name
Experience
Company Auditors
Name
Date Appointed
Years
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|